IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 52.68

Change

-0.38 (-0.72)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.86 (-0.59%)

USD 37.80B
FHLC Fidelity® MSCI Health Care In..

-0.36 (-0.52%)

USD 2.66B
FXH First Trust Health Care AlphaD..

-0.12 (-0.11%)

USD 1.07B
XHE SPDR® S&P Health Care Equipme..

-0.27 (-0.28%)

USD 0.21B
IDNA iShares Genomics Immunology an..

-0.17 (-0.75%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF

+0.25 (+0.76%)

USD 0.09B
XHS SPDR® S&P Health Care Service..

-0.41 (-0.40%)

USD 0.07B
HTEC Robo Global® Healthcare Techn..

-0.40 (-1.29%)

USD 0.05B
BBP Virtus LifeSci Biotech Product..

-0.38 (-0.61%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

-0.05 (-0.21%)

USD 6.89M

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 9.86 % 0.00 %

-0.09 (-0.31%)

USD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.77% 95% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.77% 95% A 91% A-
Trailing 12 Months  
Capital Gain 1.39% 14% F 39% F
Dividend Return 0.79% 56% F 9% A-
Total Return 2.18% 19% F 28% F
Trailing 5 Years  
Capital Gain 37.04% 62% D 65% D
Dividend Return 5.42% 63% D 14% F
Total Return 42.46% 62% D 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 5.43% 62% D 52% F
Dividend Return 6.07% 62% D 47% F
Total Return 0.64% 63% D 16% F
Risk Return Profile  
Volatility (Standard Deviation) 21.69% 43% F 50% F
Risk Adjusted Return 28.01% 57% F 42% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.